04277nam 2200553 a 450 991081670620332120240416234853.01-280-19570-397866101957010-309-57314-90-585-15528-3(CKB)110986584753404(SSID)ssj0000106823(PQKBManifestationID)11114201(PQKBTitleCode)TC0000106823(PQKBWorkID)10133232(PQKB)10936946(MiAaPQ)EBC3376661(Au-PeEL)EBL3376661(CaPaEBR)ebr10056937(OCoLC)923264831(EXLCZ)9911098658475340419940323d1993 uy 0engurcn|||||||||txtccrAn assessment of the NIH Women's Health Initiative /Committee to Review the NIH Women's Health Initiative, Food and Nutrition Board, and Board on Health Sciences Policy, Institute of Medicine ; Susan Thaul and Dana Hotra, editors1st ed.Washington, D.C. National Academy Press1993xv, 142 pBibliographic Level Mode of Issuance: Monograph0-309-04989-X Includes bibliographical references (p. 91-93).An Assessment of the NIH Women's Health Initiative -- Copyright -- Preface -- Contents -- List of Figures -- Executive Summary -- THE WOMEN'S HEALTH INITIATIVE -- THE IOM STUDY -- FINDINGS AND SUGGESTIONS -- Clinical Trial -- Factorial Design -- Sample Characteristics -- Proposed Analytic Techniques -- Ethics -- Minority Analysis Plan -- Specificity of Intervention and Effect -- Outcome Definition and Measurement -- Recruitment, Retention, and Adherence -- Secular Trends -- Provision of Health Care Services to Participants -- Cost -- Observational Study -- Community Prevention Study -- RECOMMENDATIONS -- Clinical Trial -- Observational Study -- Community Prevention Study -- RESPONSES TO THE STATEMENT OF TASK -- 1 Introduction -- DESCRIPTION OF THE NIH WOMEN'S HEALTH INITIATIVE -- HISTORY OF INSTITUTE OF MEDICINE INVOLVEMENT -- COMMITTEE SELECTION AND PARTICIPATION -- STATEMENT OF TASK -- COMMITTEE ACTIVITIES -- 2 Clinical Trial -- INTRODUCTION -- RATIONALE -- General Issues -- Integration of the CT with Other Components of the WHI -- 3 Observational Study -- RATIONALE -- DESIGN AND METHODS -- COST -- RECOMMENDATIONS -- 4 Community Prevention Study -- INTRODUCTION -- RATIONALE -- DESIGN AND METHODS -- COST -- RECOMMENDATIONS -- 5 Concluding Remarks -- RESPONSE TO THE STATEMENT OF TASK -- SOCIETAL CONTEXT -- Efficacy and Effectiveness -- Public Health Choice versus Individual Choice -- Considerations beyond Science -- References -- Appendixes -- A Clinical Trial Exclusion Criteria (June 28, 1993, WHI Protocol) -- A.  EXCLUSION CRITERIA FOR ALL COMPONENTS -- B.  ADDITIONAL EXCLUSION CRITERIA FOR ALL CLINICAL TRIAL COMPONENTS -- C.  ADDITIONAL EXCLUSION CRITERIA FOR HORMONE REPLACEMENT COMPONENT -- D.  ADDITIONAL EXCLUSION CRITERIA FOR DIETARY MODIFICATION COMPONENT -- E.  ADDITIONAL EXCLUSION CRITERIA FOR CALCIUM/VITAMIN D COMPONENT.B U.S. House of Representatives Appropriations Committee -- C Statement of Task -- D Documents Received by the Institute of Medicine from the National Institutes of Health -- E Meeting Participants June, July, and August 1993 -- F Primary and Subsidiary Hypotheses of the Women's Health Initiative Clinical Trial -- G Women's Health Initiative Committees -- H NIH-Sponsored Women's Health Studies -- I NIH Cost and FTE Summary for Vanguard Clinical Centers -- J NIH Power Calculations -- K Women's Health Initiative Clinical Coordinating Center and Vanguard Clinical Centers Principal Investigators -- M Committee and Staff Biographies -- IOM STAFF.WomenHealth and hygieneUnited StatesWomenHealth and hygiene613/.04244/0973Thaul Susan1631095Hotra Dana1631096MiAaPQMiAaPQMiAaPQBOOK9910816706203321An assessment of the NIH Women's Health Initiative3969730UNINA